ID
22111
Descripción
The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Palabras clave
Versiones (2)
- 8/5/17 8/5/17 -
- 20/5/17 20/5/17 -
Subido en
20 de mayo de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Descripción
Medication
Alias
- UMLS CUI-1
- C0013227
Descripción
Drug name
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Unit Dose
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C0869039
- UMLS CUI [1,2]
- C0013227
Descripción
Units
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C0013227
Descripción
Frequency
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3476109
- UMLS CUI [1,2]
- C0013227
Descripción
Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Reason for Medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013227
Descripción
Start Date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Descripción
Start time
Tipo de datos
time
Unidades de medida
- hh:min
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1301880
Descripción
Taken Prior to Study
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826667
Descripción
Stop Date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
Stop Time
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1522314
Descripción
Ongoing Medication
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
Sin comentarios